FMP
TriSalus Life Sciences, Inc.
TLSI
NASDAQ
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
5.14 USD
-0.02 (-0.389%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Ms. Mary T. Szela B.S.N., M.B.A.
sector
Healthcare
industry
Medical - Devices
website
https://trisaluslifesci.comexchange
NASDAQ
Description
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, C...
CIK
0001826667
ISIN
US89680M1018
CUSIP
89680M101
Address
6272 West 91st Avenue
Phone
888 321 5212
Country
US
Employee
107
IPO Date
Feb 8, 2021
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
TLSI Financial Summary
CIK
0001826667
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
89680M101
ISIN
US89680M1018
Country
US
Price
5.14
Beta
0.5
Volume Avg.
37.95k
Market Cap
156.73M
Shares
-
52-Week
3.5-10.42
DCF
-8.06
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.68
P/B
-
Website
https://trisaluslifesci.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TLSI News
It looks like there's no news available.
